Hyperion Therapeutics, Inc IPO Research Information

Hyperion Therapeutics, Inc IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Hyperion Therapeutics, Inc, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Hyperion Therapeutics, Inc	HPTX -	$11.00-$13.00	$10.00	$10.50	5 million	7/26/2012
Underwriter(s): Leerink, Cowen & Company
Co-Manager(s): Needham & Co.
Industry: Health Care
Filing(s): Filed 2012-04-13

Hyperion Therapeutics, Inc Quote & Chart - Click for current quote - HPTX

About Hyperion Therapeutics, Inc (adapted from Hyperion Therapeutics, Inc prospectus):
They are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.

This description is adapted from Hyperion HPTX prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Hyperion HPTX "HPTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.